Meniere's Disease Hearing Loss: What's Really Happening?

Meniere's disease hearing loss isn't caused by hydrops (increased fluid in the inner ear), the explanation most patients are given — it comes from two processes: temporary, attack-related loss, and a separate, permanent decline from injury to the inner ear. Most patients plateau at moderate-to-severe loss rather than progressing to deafness. While controlling attacks hasn't been shown to protect hearing, treating the underlying driver is a promising next step. Hearing aids require special care due to fluctuation, and Meniere's tinnitus follows its own distinct pattern.

WHAT OUR PATIENTS WANT TO KNOW

Topic	Quick Answer
Will hearing come back?	Early on, often yes — hearing tied to an attack usually recovers. Over time, however, there is a progressive hearing loss that is irreversible.
How bad will it get?	Most ears plateau at a moderate-to-severe loss (roughly 50–60 dB), not total deafness. Most of the decline happens in the first several years.
Do hearing aids help?	Sometimes. Meniere's hearing fluctuates, so a setting that works one week may not work the next. Also, if word understanding is less than 50%, then you need special consideration.

Meniere's disease hearing loss is one of the biggest concerns for people struggling with this condition. Understanding what's actually happening can provide critical guidance to those who suffer from it.

In this article, we'll break down what happens to hearing with Meniere’s disease and what you can do about it.

IMPORTANT: If you're suffering from Meniere's disease hearing loss and are looking for treatment, schedule a Program Consultation with our team.

What Is Meniere's Disease Hearing Loss?

Meniere's disease hearing loss has two distinct components: fluctuating hearing loss during attacks and progressive hearing loss over time. Attack-related hearing loss is temporary and typically improves as the episode resolves. Separately, cumulative injury within the inner ear can cause permanent hearing loss that gradually worsens, particularly during the earlier years of the disease.

What Does Meniere's Hearing Loss Sound Like?

Meniere's hearing loss typically makes sounds seem muffled, faint, or far away. Unlike age-related hearing loss, which usually affects high frequencies, Meniere's disease typically affects low frequencies first. This can reduce the fullness and volume of speech while leaving much of its clarity intact.

Low frequencies carry much of the “body” of speech, including vowels, voicing, and fullness. This creates a different listening experience:

• Meniere's hearing loss: speech may sound faint, hollow, or distant.
• Age-related hearing loss: speech is more likely to sound clear in quiet, but mumbled when there is background noise.

Phone conversations for low-frequency hearing loss can be especially difficult. Phone audio emphasizes the low-to-mid frequencies affected by Meniere's disease and removes the visual cues that help compensate during face-to-face conversation.

How Common Is Hearing Loss in Meniere's Disease?

Hearing loss is a defining feature of Meniere's disease. In fact, documented hearing loss is required for a diagnosis of definite Meniere's disease. By the time many patients are diagnosed, the loss is already substantial: one large study found an average hearing threshold of about 45 dB, with 56% of patients already at Stage III (see below) [1].

How Bad Does Meniere's Hearing Loss Get?

Meniere's hearing decline typically occurs during the first several years of the disease and then tends to plateau, with average hearing thresholds leveling off at approximately 50–60 dB, in the moderate-to-severe range [2].

Where that plateau lands can vary. One long-term study found patients with a better overall prognosis leveled off around 35 dB, while those with a worse prognosis still stabilized — but at a higher plateau, closer to 50-60 dB [3]. Generally, as long as you are getting attacks, you will continue to lose hearing, but the loss does not progress to deafness.

Typical Course	What Happens
Early years	Most hearing loss develops during the first several years
Later course	Hearing loss tends to level off
Long-term hearing loss	Average loss is approximately 50–60 dB [2]
Bilateral disease	Develops in approximately 13–15% of patients [5]
Total deafness	Uncommon

Sudden Hearing Loss Presentation Is Higher Risk

About 1 in 5 Meniere's patients experiences a sudden hearing hearing at the onset of the disease (rather than a gradual decline). In a 2026 study, researchers found that patients who present initially with sudden hearing loss have a higher risk of worse hearing loss after 10 years (47%) with a significantly worse pure tone averages (PTA) after 10 years of progression.

Can Meniere's Hearing Loss Affect Both Ears?

Meniere's disease can eventually affect both ears, but most patients with one-sided disease remain unilateral. A 2025 meta-analysis of more than 1,500 patients found that about 13% developed bilateral Meniere's disease, with second-ear involvement occurring an average of about 8 years later [5].

Long-Term Finding	What the Data Show
Risk of bilateral disease	About 13% [5]
Average time to second-ear involvement	About 8 years [5]
Risk window	Can remain elevated for 20+ years after diagnosis [5]

This bilateral rate is substantially lower than estimates in older literature, which sometimes reached 50%. More recent estimates reflect stricter diagnostic criteria and better long-term follow-up.

Key Point: Second-ear involvement is uncommon, but it can occur many years after the initial diagnosis. Continued hearing testing in the unaffected ear can help identify changes early.

Meniere's Disease Audiogram

How Hearing Loss Changes in Meniere's Disease

Point in the Disease	Typical Audiogram Finding
Early	Fluctuating hearing loss, usually greatest at low frequencies
As hearing loss progresses	Middle and higher frequencies become involved
Later	Hearing loss may become more permanent and the audiogram flatter
Alternative pattern	Some patients develop a peak-shaped audiogram, with better hearing in the middle frequencies

Much of this progression tends to occur during the first several years rather than gradually over decades. This differs from age-related hearing loss, which typically develops slowly and predominantly affects the higher frequencies.

4 Stages of Meniere's Disease Hearing Loss

Meniere's disease is traditionally staged according to hearing severity. This is the official “4 stages of Meniere's disease” and it differs from the more commonly described clinical stages of Meniere's disease (which follow the disease from early onset through later-stage “burnout”).

Staging uses the worst pure-tone average (PTA) measured during the six months before treatment. In one long-term study, only about one-third of patients were Stage I or II at their first visit, while most were already Stage III or IV [6]. Patients were more likely to remain in the milder stages long-term if they were younger than 58 and had better hearing at their first visit [6].

Word Recognition in the Meniere's Disease Audiogram

Pure-tone hearing thresholds do not tell the whole story in Meniere's disease. Word recognition can be disproportionately poor, meaning a patient may hear that someone is speaking but still have difficulty understanding the words [7].

A detailed study of Meniere's ears helps explain why [8]:

What Researchers Measured	What They Found
Sound-sensing hair cells	Nearly half remained
Auditory nerve fibers	Fewer than one-third remained
Average word recognition	Just 37%
Best predictor of word recognition	Auditory nerve-fiber survival

The findings suggest that auditory nerve damage may contribute to speech difficulties beyond what is apparent on the pure-tone audiogram [8]. This can become particularly noticeable in background noise, group conversations, or on the phone.

How Often Should You Get an Audiogram for Meniere's Disease?

People with Meniere's disease should generally have an audiogram at least once a year, with additional testing when hearing changes. Because hearing can fluctuate, a single audiogram provides only a snapshot.

Serial audiograms serve three purposes:

• Track whether hearing loss is fluctuating or becoming permanent
• Measure long-term changes in hearing severity
• Establish a baseline for detecting changes in the opposite ear

How Does Meniere's Disease Cause Hearing Loss?

Meniere's hearing loss comes from an upstream injury to the nerve supply and blood vessels of the inner ear — not from endolymphatic hydrops, the explanation most patients have been given. This distinction matters because it explains what the fluid-pressure model can't:

• Why hearing damage can appear before fluid buildup develops
• Why some ears with hydrops still have normal hearing
• Why hearing can keep declining despite fluid-targeted treatment

What Causes Fluctuating Hearing Loss During a Meniere's Attack?

Fluctuating hearing loss during a Meniere's attack appears to result from a temporary disruption of cochlear function rather than permanent damage. For instance, during an attack, shifts in inner-ear fluid from neurovascular changes can temporarily block the transduction channels that hair cells use to convert sound vibrations into nerve signals [9].

The hair cells themselves are not necessarily injured or destroyed. Instead, they temporarily stop functioning normally, which helps explain why hearing can decline during an attack and then recover afterward.

What triggers Meniere's hearing loss?

The proposed upstream trigger for that fluid shift is the same migraine-related neurovascular activity that drives the rest of Meniere's disease:

Migraine activation → CGRP release → altered cochlear blood flow → fluid/ion shift → transduction-channel blockade

Evidence supports several links in this proposed chain:

Mechanism	What the Evidence Suggests
Trigeminal/CGRP signaling	These pathways directly innervate cochlear blood vessels
Cochlear function	CGRP can reversibly alter cochlear function
Role of hydrops	Hydrops may make the inner ear more vulnerable to vascular changes, but not itself cause the hearing loss.
Hearing recovery	As blood flow and ion balance normalize, transduction channels can reopen and hearing can recover

What Causes the Permanent, Progressive Hearing Loss?

Permanent hearing loss in Meniere's disease comes from structural damage to the auditory nerve fibers and the small blood vessels that support them [10]. Unlike the temporary functional disruption during an attack, this damage accumulates over time and does not reverse.

The proposed model is that repeated neurovascular disruption gradually becomes structural injury:

Repeated changes in blood flow and inflammation → vascular stress → auditory nerve-fiber degeneration → permanent hearing loss

Importantly, this damage may begin BEFORE endolymphatic hydrops develops. Studies of the unaffected ear in one-sided Meniere's disease have found [10,11]:

• Strial and vascular changes despite no hydrops or hearing loss
• Early nerve-cell loss in some unaffected ears
• Blood vessel loss before measurable hearing loss develops

The authors of a 2026 Meniere's temporal bone study note that “lateral wall histopathology may be the earliest site of cochlear damage in this disease” [11].

Key Point: These findings suggest that neurovascular injury may occur upstream, with hydrops and hearing loss developing later as downstream consequences rather than fluid pressure itself being the primary cause.

Why Does Meniere's Affect Low-Frequency Hearing First?

Meniere's disease affects low-frequency hearing first because this region of the cochlea appears to be particularly vulnerable to the disease process, not because hydrops starts there. In fact, low-frequency dysfunction can develop BEFORE hydrops is detectable [12]. Two findings support this:

• The timing is backwards for a fluid-pressure explanation. In animal studies, low-frequency dysfunction appeared first, while hydrops developed later and actually began in the high-frequency region [12].
• There may be a built-in biological vulnerability. PRKCB, a gene linked to inherited Meniere's disease, is particularly active in support cells of the low-frequency regions of the cochlea [13].

Together, this suggests Meniere's characteristic low-frequency hearing loss reflects regional cochlear vulnerability rather than the location of fluid buildup (i.e., hydrops).

Why Does Meniere's Hearing Loss Plateau Instead of Progressing to Deafness?

Meniere's hearing loss usually plateaus and flattens because the underlying degenerative process reaches a natural endpoint. A study of Meniere's temporal bones found that disease duration made surprisingly little difference to the extent of damage — the injury pattern was already largely established, suggesting the process runs its course to a common endpoint rather than continuing to worsen indefinitely [11].

Two factors help explain why that endpoint isn't total deafness:

• The vulnerable cells are consumed early, then the process runs out of easy targets. The fine nerve fibers that carry sound are lost early and severely, but the nerve cell bodies they connect to are much more resistant to injury and are largely preserved even after their fibers are gone [11].
• What's preserved still produces usable hearing. Because a meaningful share of the underlying auditory-nerve architecture survives, thresholds settle at a floor rather than progressing to complete deafness.

That preservation of nerve cell bodies is also important because it helps explain why cochlear implants can work well in advanced Meniere's disease.

Can You Stop Meniere's Disease Hearing Loss?

Standard treatment approaches have failed to halt the progressive hearing loss in Meniere's disease. These treatments may reduce attacks, but hearing can continue to decline even when vertigo improves. Here is what the evidence shows:

1. Controlling Vertigo Alone Does Not Protect Hearing

The long-term evidence is fairly consistent in showing that controlling vertigo alone does not preserve hearing:

• A 2024 meta-analysis of 950 patients across 13 studies found significant hearing decline after two years regardless of medical therapy [14].
• Another study found that vertigo improved while hearing continued to worsen [15].

2. We May Have Been Targeting the Wrong Problem

Most traditional treatments, including diuretics, salt restriction, and betahistine, were developed around the idea that hydrops is driving the disease. But as discussed above:

Neurovascular injury may begin first → hydrops develops later → permanent hearing loss follows

If that model is correct, treating hydrops alone does not address the upstream process that may be damaging hearing.

3. Hearing Damage May Start Before Symptoms

Per the evidence above, neurovascular damage may begin before attacks, hydrops, or measurable hearing loss appear. Changes have been found in the unaffected ear of patients with one-sided Meniere's disease, suggesting the disease process may already be underway before a patient notices anything is wrong [10,11].

By the time Meniere's disease is diagnosed, some of this injury may have already been accumulating for months or even years.

4. Hearing Preservation Requires a Neurovascular Target

Current evidence increasingly ties progressive hearing loss in Meniere's disease to neurovascular injury within the cochlea, rather than hydrops alone. If neurovascular injury is the process damaging hearing, then it becomes the logical treatment target.

Newer protocols that address migraine-related neurovascular dysfunction are therefore targeting the same biological process implicated in cochlear injury.

What This Means for Hearing Preservation

Taken together, the evidence points toward treating the upstream neurovascular process early, rather than waiting for hydrops or hearing loss to progress.

What We've Learned	What It Changes
Vertigo control does not equal hearing protection	Hearing may continue to decline even when attacks improve. Hearing preservation needs to be a separate treatment goal.
Hydrops may be the wrong primary target	Traditional treatments focus on inner-ear fluid, but the process causing permanent hearing damage may occur upstream of hydrops.
Neurovascular injury may start early	Damage may begin before hydrops or measurable hearing loss. Delaying effective treatment may allow irreversible injury to accumulate.
Migraine provides a neurovascular treatment target	Migraine-directed protocols target the neurovascular dysfunction increasingly implicated in cochlear injury, rather than focusing only on downstream fluid changes.

The New Paradigm: Treat the Driver, Not the Fluid

If migraine-related neurovascular (nerve/blood vessel interaction) injury is what's actually driving both the attacks and the progressive damage, then the logical target isn't the attacks themselves — it's the process generating them.

Given how early the damage may begin, migraine-informed Meniere's disease treatment started at the point of typical diagnosis may slow the loss going forward rather than reverse what's already happened.

Early evidence supports this migraine-informed approach. Calcitonin gene-related peptide (CGRP) is a signaling molecule central to migraine biology and has emerged as a specific point of interest for understanding and potentially preventing cochlear injury:

• Pre-clinical: Animal studies show CGRP can directly injure cochlear tissue, and CGRP-blocking drugs reduce that injury in those models [16].
• Clinical: In a small, uncontrolled human case series, patients with both Meniere's disease and migraine had their Meniere's symptoms resolve on a CGRP-blocking medication, including the hearing loss [17].

Until this approach is proven in a prospective clinical trial, “promising preliminary results” remains the most accurate description. However, our early clinical experience supports this emerging treatment paradigm and its potential to preserve hearing.

Meniere's Disease and Hearing Aids

Hearing aids can help with Meniere's disease, but they're a harder fit than standard age-related hearing loss. Meniere's hearing doesn't stay stable — it can shift week to week, or attack to attack — so a fitting that works today may not work next month. However, once you address this issue, many Meniere's patients benefit from using hearing aids.

The Problem With Meniere's Disease Hearing Aids

Meniere's hearing loss creates several specific fitting challenges that a standard hearing aid isn't built to handle:

• Fluctuation — your hearing today may not match your hearing next month, so a fitting that works one week can feel too soft, too loud, or distorted the next
• Rising audiogram shape — most hearing aids are tuned for high-frequency loss, the opposite of the low-frequency pattern in Meniere's disease
• Narrow comfort range — the gap between “too quiet to hear” and “too loud to tolerate” is smaller than usual, so overamplifying can make things worse rather than better
• Reduced word clarity — even with enough volume, speech can still sound unclear, for the same reason discussed earlier in this article [7,8]

Do Hearing Aids for Meniere's Disease Work?

Yes — hearing aids can meaningfully help, but success depends on matching the device to these specific problems rather than treating Meniere's like ordinary age-related hearing loss. The adaptation that makes the biggest difference is letting patients adjust their own aids in real time.

In a 40-patient study of programmable, self-adjustable hearing aids [18]:

• Every single participant showed measurable hearing fluctuation over 8 weeks
• 70% of patients kept adjusting their own devices throughout the study
• Patients reported high satisfaction, specifically because they could compensate as their hearing changed

Key Point: it's the fluctuation itself, not just the underlying loss, that needs to be managed. Patients who can self-adjust their devices will wear them more often and report feeling more in control of their hearing [19].

Advanced Hearing Aids for Meniere's Disease

A few approaches specifically address the fluctuation and asymmetry problems in Meniere's disease:

Approach	What It Solves
Multiple listening programs	Separate settings for a “good hearing” day versus a flare, switched as needed
Self-adjustable / self-programming aids	Lets the patient fine-tune in real time rather than waiting on a new office fitting
CROS / BiCROS devices	Routes sound from a poor-hearing ear to a better-hearing ear, for one-sided loss with a usable other ear
Bone-anchored devices	Similar use case to CROS, often preferred when a patient doesn't want a device in the ear itself but has one non-usable ear

Cochlear Implants for Meniere's Disease

When word recognition falls below about 50%, a hearing aid stops being useful — it can make sound louder without making it any clearer. At that point, a cochlear implant tends to work unusually well specifically for Meniere's patients.

Here's why: the nerve fibers carrying the sound signal are often severely damaged in Meniere's disease, but the nerve cell bodies they connect to are usually well preserved. A cochlear implant bypasses the damaged part entirely and stimulates that surviving nerve directly.

That's exactly why outcomes tend to be strong:

• 50–57% average improvement in word recognition after implantation, consistent across multiple studies [20,21]
• Benefit holds regardless of how long a patient has had the disease [20]
• Tinnitus and vertigo symptoms often improve too, not just hearing [20]

Meniere's Disease Tinnitus

Meniere's disease tinnitus follows a recognizable pattern during attacks — a low-frequency roaring alongside the drop in hearing — but between attacks, it's more varied than most patients expect, and how loud or high-pitched it sounds has surprisingly little to do with how much it actually bothers you.

What Does Meniere's Tinnitus Sound Like?

Meniere's tinnitus sounds different depending on whether a person is during or between attacks. The classic description is “roaring” — and this applies during attacks. The description is specific enough that it's actually a useful diagnostic clue pointing toward Meniere's disease [22].

However, between attacks, Meniere's tinnitus doesn't reliably settle into one consistent sound. It can be noise-like and low-pitched, or a higher tone above 3 kHz, so the classic “low and roaring” description really applies during attacks and isn't the full picture [23].

When	What It Sounds Like
During an attack	A low-frequency roaring, alongside the drop in hearing and sense of fullness
Between attacks (baseline)	Varies — some patients hear a low, noise-like roar; others hear a higher-pitched tone

Is Meniere's Tinnitus Worse Than Regular Tinnitus?

Meniere's tinnitus tends to be more severe than tinnitus from many other causes. Studies report average THI scores of about 49–51 out of 100, placing the average Meniere's patient in the moderate tinnitus-burden range [22].

In direct comparisons, Meniere's tinnitus was significantly more severe than tinnitus caused by acoustic trauma or otosclerosis, with a substantial subset of Meniere's patients experiencing severe or even catastrophic tinnitus [22].

The Best Meniere's Disease Tinnitus Treatment

The best treatment for Meniere's tinnitus addresses the disease process driving it, not just the sound itself — because Meniere's tinnitus is a symptom of an underlying inner-ear and brain-network process, not an isolated hearing problem.

Our approach is multimodal, targeting both the migraine-related mechanisms driving the disease and the brain networks that sustain tinnitus once it's present:

• Migraine-directed medical therapy — addresses the underlying neurovascular process linked to both the disease and its tinnitus
• Meniere's disease diet – one directed towards migraine-related triggers, not salt restriction.
• Cognitive behavioral therapy — retrains the brain's threat response to tinnitus, since distress is driven by anxiety and attention, not loudness
• Sound therapy — reduces the contrast between tinnitus and silence, making it less intrusive day to day
• Autonomic and stress regulation — lowers the overall reactivity that amplifies tinnitus perception
• Sleep optimization — supports the nervous system's ability to regulate sensory input, including tinnitus

Conclusion: Working Towards A Solution for Meniere's Disease Hearing Loss

Meniere's disease causes temporary hearing changes during attacks and a slower, permanent decline over time. Evidence increasingly suggests that this progressive loss involves neurovascular and auditory nerve injury rather than hydrops alone.

This creates a new opportunity for treatment. Instead of simply controlling fluid and vertigo attacks, newer migraine-directed approaches target the upstream processes that may be damaging the inner ear. Early clinical experience suggests this may help stabilize hearing and potentially halt further progression, although more research is needed.

For patients, the goal is increasingly shifting from managing hearing loss after it occurs to protecting the hearing that remains. This means seeing a Meniere's disease specialist who is current on the new paradigm of care.

If you're experiencing Meniere's-related hearing loss, schedule a Program Consultation to understand your hearing loss and treatment options.

Meniere's Disease Hearing Loss FAQs

Meniere's Disease Hearing Loss References

1. Zhang Y, Liu B, Wang R, Jia R, Gu X. Characteristics of the Cochlear Symptoms and Functions in Meniere's Disease. Chin Med J. 2016.
2. Huppert D, Strupp M, Brandt T. Long-Term Course of Menière's Disease Revisited. Acta Otolaryngol. 2010.
3. Sato G, Sekine K, Matsuda K, et al. Long-Term Prognosis of Hearing Loss in Patients With Unilateral Ménière's Disease. Acta Otolaryngol. 2014.
4. Rodriguez-Rivas P, Soto-Varela A, Vazquez-Cancela O, et al. Influence of the Type of Onset of Hearing Loss in the Hearing Impairment After Long Time Progression in Menière's Disease. Eur Arch Otorhinolaryngol. 2026.
5. Hudson TJ, Tan LSH, Phillips V, Muzaffar J, Bance M. Long-Term Risk of Progression From Unilateral to Bilateral Ménière's Disease: A Systematic Review and Meta-Analysis. Otol Neurotol. 2025.
6. Cheng PC, Chang CY, Chen TA, et al. Long-Term Hearing Outcomes and Prognostic Factors in Meniere's Disease. Acta Otolaryngol. 2026. [Attribution to be verified against source before publication]
7. Lorente-Piera J, Blanco M, Santos-Garrido J, et al. Functional Audiometric Dissociation in Ménière's Disease: Exploring the Mismatch Between Pure-Tone Thresholds and Speech Recognition. J Clin Med. 2025.
8. Kaur C, Wu PZ, O'Malley JT, Liberman MC. Cochlear Neural Degeneration Is Key to the Variation in Word Scores Among People With Similar Thresholds. Hear Res. 2026.
9. Fong ML, Paik CB, Quiñones PM, et al. Endolymphatic Hydrops and Cochlear Synaptopathy After Noise Exposure Are Distinct Sequelae of Hair Cell Stereociliary Bundle Trauma. Sci Rep. 2024.
10. Curry SD, Lopez IA, Ishiyama G, Ishiyama A. Changes in the Neurovascular Unit in Meniere's Disease. Otol Neurotol. 2025.
11. Kaur C, Wu PZ, Eckhard AH, O'Malley JT, Liberman MC. Cochlear Neural Degeneration Is Widespread in Ménière's Disease: A Temporal Bone Study. J Assoc Res Otolaryngol. 2026.
12. Lee C, Valenzuela CV, Goodman SS, et al. Early Detection of Endolymphatic Hydrops Using the Auditory Nerve Overlapped Waveform (ANOW). Neuroscience. 2020.
13. Martín-Sierra C, Requena T, Frejo L, et al. A Novel Missense Variant in PRKCB Segregates Low-Frequency Hearing Loss in an Autosomal Dominant Family With Meniere's Disease. Hum Mol Genet. 2016.
14. Thompson-Harvey A, Pyle M, Harvey E, Harris MS. Effect of Non-Ablative Medical Therapy on Progression of Hearing Loss in Menière's Disease: A Systematic Review and Meta-Analysis. Otol Neurotol. 2024.
15. Fukushima M, Ueno Y, Kitayama I, et al. Assessment of the Progression of Vertical Semicircular Canal Dysfunction and Increased Vestibular Endolymphatic Hydrops in Patients With Early-Stage Ménière Disease. JAMA Otolaryngol Head Neck Surg. 2020.
16. Koçdor P, Shomalizadeh N, Salman FA, et al. Cochlear Functional Changes and CGRP Modulation in a Chronic Nitroglycerin Migraine-Like Rat Model. Eur J Neurosci. 2026.
17. Hegemann SCA, Schell A. Treating Menière's Disease With Rimegepant. Swiss Med Wkly. 2025.
18. McNeill C, McMahon CM, Newall P, Kalantzis M. Hearing Aids for Ménière's Syndrome: Implications of Hearing Fluctuation. J Am Acad Audiol. 2008.
19. Gomez R, Habib A, Maidment DW, Ferguson MA. Smartphone-Connected Hearing Aids Enable and Empower Self-Management of Hearing Loss: A Qualitative Interview Study Underpinned by the Behavior Change Wheel. Ear Hear. 2021.
20. Berardino FD, Conte G, Turati F, Ferraroni M, Zanetti D. Cochlear Implantation in Ménière's Disease: A Systematic Review of Literature and Pooled Analysis. Int J Audiol. 2020.
21. Chien CY, Kulthaveesup A, Herrmann BS, Rauch SD. Cochlear Implantation Hearing Outcome in Ménière's Disease. Otolaryngol Head Neck Surg. 2022.
22. Perez-Carpena P, Martinez-Martinez M, Martínez Carranza RA, Batuecas-Caletrio A, Lopez-Escamez JA. A Tinnitus Symphony in 100 Patients With Meniere's Disease. Clin Otolaryngol. 2019.
23. Ueberfuhr MA, Wiegrebe L, Krause E, Gürkov R, Drexl M. Tinnitus in Normal-Hearing Participants After Exposure to Intense Low-Frequency Sound and in Ménière's Disease Patients. Front Neurol. 2017.